Neurology Specific Literature Search   
 
[home][thesaurus]
    

Enter your terms
above and click
the 'Search' button.
Showing articles 0 to 15 of 15

Filter Applied: HMGcoA reductase inhibitors (Click to remove)

Cholesterol and Strokes
BMJ 320:459-460, Oliver,M.F., 2000

Reduction in Carotid Arterial Wall Thickness Using Lovastatin & Dietary Therapy
Ann Int Med 124:548-556, Hodis,H.N.,et al, 1996

Pravastatin Reduces Carotid Intima-Media Thickness Prog in an Asympt Hypercholesterolemic Pop, CAIUS Study
Am J Med 101:627-634, Mercuri,M.,et al, 1996

Clinicopathologic Conference, Statin-Associated Autoimmune Myopathy
NEJM 381:275-283, Case 22-2019, 2019

Hemorrhagic Stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels Study
Neurol 70:2364-2370,2355, Goldstein,L.B.,et al, 2008

Antiplatelets, ACE Inhibitors, and Statins Combination Reduces Stroke Severity and Tissue At Risk
Neurol 66:1153-1158, Kumar,S.,et al, 2006

HMG-CoA Reductase Inhibitors Improve Acute Ischemic Stroke Outcomes
Stroke 36:1298-1300, Moonis,M.,et al, 2005

Hypercholesterolemia, HMG-CoA Reductase Inhibitors, and Risk of Intracerebral Hemorrhage
Stroke 35:1360-1364, Woo,D.,et al, 2004

Suppression of Recurrent Transient Ischemic Attacks by a Statin Agent
Neurol 56:531-532, Alberts,M.J., 2001

Statins for Stroke Prevention?
Lancet 357:1548-1549, Sandercock,P., 2001

HMG-CoA Reductase Inhibitors (Statins)
Neurol 54:790-795, Hess,D.C.,et al, 2000

Pravastatin Therapy and The Risk of Stroke
NEJM 343:317-326, White,H.D. et al, 2000

Prevention of a First Stroke,A Review of Guidelines and a Multidisciplinary Consensus Statement from the National Stroke Association
JAMA 281:1112-1120,1146, Gorelick,P.B.,et al, 1999

Neuroprotective Properties of Statins in Cerebral Ischemia and Stroke
Stroke 30:1969-1973, Vaughan,C.J.&Delanty,N., 1999

Effect of HMGcoA Reductase Inhibitors on Stroke, A Meta-Analysis of Controlled Trials
Ann Int Med 128:89-95, Bucher,H.C.,et al, 1998



Showing articles 0 to 15 of 15